A study of medial and lateral temporal lobe epilepsy based on stereoelectroencephalography / 中华医学杂志(英文版)

BACKGROUND@#Patients with temporal lobe epilepsy (TLE) originating from different seizure onset zones had distinct electrophysiological characteristics and surgical outcomes. In this study, we aimed to investigate the relationship between the origin and prognosis of TLE, and the stereoelectroencephalography (SEEG) features.@*METHODS@#Thirty patients with TLE, who underwent surgical treatment in our functional neurosurgery department from January 2016 to December 2017, were enrolled in this study. All patients underwent anterior temporal lobectomy after an invasive pre-operative evaluation with SEEG. Depending on the epileptic focus location, patients were divided into those with medial temporal lobe seizures (MTLS) and those with lateral temporal lobe seizures (LTLS). The Engel classification was used to evaluate operation effectiveness, and the Kaplan-Meier analysis was used to detect seizure-free duration.@*RESULTS@#The mean follow-up time was 25.7 ± 4.8 months. Effectiveness was 63.3% for Engel I (n = 19), 13.3% for Engel II, 3.3% for Engel III, and 20.0% for Engel IV. According to the SEEG, 60.0% (n = 18) had MTLS, and 40.0% (n = 12) had LTLS. Compared with the MTLS group, the operation age of those with LTLS was significantly greater (26.9 ± 6.9 vs. 29.9 ± 12.5 years, t = -0.840, P = 0.009) with longer epilepsy duration (11.9 ± 6.0 vs. 17.9 ± 12.1 years, t = -1.801, P = 0.038). Patients with MTLS had a longer time interval between ictal onset to seizure (67.3 ± 59.1 s vs. 29.3 ± 24.4 s, t = 2.017, P = 0.008). The most common SEEG ictal pattern was a sharp/spike-wave rhythm in the MTLS group (55.6%) and low-voltage fast activity in the LTLS group (58.3%). Compared with the LTLS group, patients with MTLS had a more favorable prognosis (41.7% vs. 77.8%, P = 0.049). Post-operative recurrence was more likely to occur within three months after the operation for both groups, and there appeared to be a stable long-term outcome.@*CONCLUSION@#Patients with MTLS, who accounted for three-fifths of patients with TLE, showed a more favorable surgical outcome.

Characteristics of Trunk Muscles in Isokinetic Training at Different Velocities / 中国康复理论与实践

Objective:To study the presentation and changes of trunk flexors and extensors in isokinetic training at different velocities. Methods:From March to September, 2018, 27 health volunteers were enrolled. Their peak torques of trunk flexors and extensors at 30°/s, 60°/s, and 90°/s were collected. Results:The peak torques of trunk flexors and extensors slightly decreased with the increasing of velocities, but no significant difference was found (F < 2.070, P > 0.05). At 30°/s and 60°/s, the peak torque of extensors was higher than that of flexors (t > 3.138, P < 0.01); at 90°/s, no significant difference was found in the peak torque between flexors and extensors (t = -0.946, P > 0.05). The ratios of the peak torque of flexors to extensors were 0.79∶1 both at 30°/s and 60°/s. The peak torque of flexors decreased in the tenth contraction compared with the second contraction at all the angular velocities, however, it was significantly different only at 30°/s (t = 5.159, P < 0.01); meanwhile, the peak torque of extensors increased with significance only at 60°/s (t = -2.142, P < 0.05). Conclusion:At 30°/s and 60°/s, there might be a linear relation between trunk flexors and extensors, and the peak torque ratios of trunk flexors to extensors were approximately the same.

Study on protective effects of Panax notoginseng saponins on doxorubicin-induced myocardial damage / 中国中药杂志

<p><b>OBJECTIVE</b>To study the effects of Panax notoginseng saponins (PNS) on acute doxorubicin-induced myocardial injury in mice and the anti-tumor efficiency of doxorubicin.</p><p><b>METHOD</b>Mice were given a dose of 15 mg x kg(-1) doxorubicin ip alone or in combination with 25, 50, 100 mg x kg(-1) PNS ig, 5 days before doxorubicin administration and following 3 days. Cardiotoxic effects were measured by serum levels of dehydrogenase (LDH), creatine kinase (CK) and creatine kinase isoenzyme (CK-MB) and activities of antioxidant enzymes in heart tissue. In vitro experiments were performed using embryonic rat heart cell H9C2 to assess the protective effect of PNS (6.25-100 mg x L(-1)) against doxorubicin on cell viability. Anti-tumor efficiency of doxorubicin was evaluated by cytotoxic experiments using three cancer cell lines.</p><p><b>RESULT</b>Pretreatment with PNS significantly lowered the levels of serum LDH, CK and CK-MB, and normalized myocardial superoxide dismutase, glutathione peroxidase and catalase activities. PNS also attenuated the inhibitory effect of doxorubicin on the viability of H9C2 cells, but did not compromise its inhibitory effect on proliferation of cancer cells.</p><p><b>CONCLUSION</b>PNS was demonstrated to attenuate doxorubicin-induced myocardial damage without compromising its anti-tumor activity.</p>